Author

W. Liu

OpenAlex ID: A5063892829

Abstract A4: Phase I clinical trial evaluating the safety, pharmacokinetics and biological effect of intravenous bevacizumab (avastin) in combination with escalating doses of AZD2171 (cediranib) administered orally for 21 consecutive days to patients with advanced malignancies (NCI protocol #7534)

2009 · David S. Hong, Darrin Davis, et al. · Molecular Cancer Therapeutics · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: